Results 241 to 250 of about 1,205,764 (269)

Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT receptor agonist and A receptor antagonist

Neuropharmacology, 2021
Giulia Costa, Annalisa Pinna, Micaela Morelli   +2 more
exaly  

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia

Expert Review of Neurotherapeutics, 2021
Joohi Jimenez-Shaheed
exaly  

Abnormal Involuntary Movement Scale

2013
Maureen Early, Logan Wink, Craig A. Erickson, Christopher J. McDougle   +3 more
openaire   +1 more source

Abnormal Involuntary Movements and Chronic Obstructive Pulmonary Disease

Journal of Clinical Psychopharmacology, 1983
R J, Campbell, W E, Fann, J I, Thornby
openaire   +2 more sources

On the pathogenesis of abnormal involuntary movements in lithium-treated patients with major affective disorder

European Archives of Psychiatry and Clinical Neuroscience, 1991
R Axelsson, Agneta Nilsson
exaly  

Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients

Movement Disorders, 1996
Patricia Limousin, Abdelhamid Benazzouz, Alim Louis Benabid   +2 more
exaly  

Other abnormal involuntary movements

2005
openaire   +1 more source

Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: Results of a population-based study

Schizophrenia Research, 2016
Stefanie J Schmidt, Katharina Stegmayer, Benno Schimmelmann   +2 more
exaly  

Association between the Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2007
Dana J Niehaus, Willem Botes, Louise Warnich   +2 more
exaly  

Other abnormal involuntary movements

2012
openaire   +1 more source